Yan D - Search Results

1

Pyruvate Kinase M2-Responsive Release of Paclitaxel and Indoleamine 2,3-Dioxygenase Inhibitor for Immuno-Chemotherapy of Nonsmall Cell Lung Cancer.

Wu H, Sun X, Li K, Li J, Jiang H, Yan D, Lin Y, Ding Y, Lu Y, Zhu X, Chen X, Li X, Liang G, Xu H. Wu H, et al. Among authors: yan d. Adv Sci (Weinh). 2024 Dec 24:e2409790. doi: 10.1002/advs.202409790. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39716923

2

Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy.

Wu T, Yan D, Hou W, Jiang H, Wu M, Wang Y, Chen G, Tang C, Wang Y, Xu H. Wu T, et al. Among authors: yan d. Cancers (Basel). 2022 Sep 18;14(18):4520. doi: 10.3390/cancers14184520. Cancers (Basel). 2022. PMID: 36139680 Free PMC article.

3

[Experimental study on the effect of Yiqi Wenyang Decoction on nasal mucosa infiltration of NK cells in mice with allergic rhinitis].

Chen XQ, Ma Q, Zhou LY, Ma HA, Wu JY, Zhao JJ, Yan DN. Chen XQ, et al. Among authors: yan dn. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Dec 7;52(12):921-926. doi: 10.3760/cma.j.issn.1673-0860.2017.12.009. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 29262451 Chinese.

4

A responsive porous hydrogel particle-based delivery system for oncotherapy.

Wen Y, Liu Y, Zhang H, Zou M, Yan D, Chen D, Zhao Y. Wen Y, et al. Among authors: yan d. Nanoscale. 2019 Feb 7;11(6):2687-2693. doi: 10.1039/c8nr09990a. Nanoscale. 2019. PMID: 30693935

5

High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.

Sun Y, Yan C, Xie J, Yan D, Hu K, Huang S, Liu J, Zhang Y, Gu N, Xiong F. Sun Y, et al. Among authors: yan d, yan c. ACS Appl Mater Interfaces. 2019 Aug 21;11(33):29536-29548. doi: 10.1021/acsami.9b08948. Epub 2019 Aug 6. ACS Appl Mater Interfaces. 2019. PMID: 31333014

6

Intelligent phototriggered nanoparticles induce a domino effect for multimodal tumor therapy.

Xu X, Han C, Zhang C, Yan D, Ren C, Kong L. Xu X, et al. Among authors: yan d. Theranostics. 2021 Apr 19;11(13):6477-6490. doi: 10.7150/thno.55708. eCollection 2021. Theranostics. 2021. PMID: 33995669 Free PMC article.

7

Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.

Ren C, Xu X, Yan D, Gu M, Zhang J, Zhang H, Han C, Kong L. Ren C, et al. Among authors: yan d. Acta Biomater. 2022 Jul 1;146:465-477. doi: 10.1016/j.actbio.2022.04.035. Epub 2022 May 6. Acta Biomater. 2022. PMID: 35526738

8

DT-diaphorase triggered theranostic nanoparticles induce the self-burst of reactive oxygen species for tumor diagnosis and treatment.

Yan D, Xu X, Ren C, Chen C, Luo J, Han C, Kong L. Yan D, et al. Acta Biomater. 2021 Apr 15;125:267-279. doi: 10.1016/j.actbio.2021.02.033. Epub 2021 Feb 27. Acta Biomater. 2021. PMID: 33652166

9

Cytochrome c light-up graphene oxide nanosensor for the targeted self-monitoring of mitochondria-mediated tumor cell death.

Han C, Xu X, Zhang C, Yan D, Liao S, Zhang C, Kong L. Han C, et al. Among authors: yan d. Biosens Bioelectron. 2021 Feb 1;173:112791. doi: 10.1016/j.bios.2020.112791. Epub 2020 Nov 5. Biosens Bioelectron. 2021. PMID: 33190048

10

PROTAC Nanoplatform with Targeted Degradation of NAD(P)H:Quinone Oxidoreductase 1 to Enhance Reactive Oxygen Species-Mediated Apoptosis.

Zhang H, Xu X, Yan D, Ren C, Zhang J, Gu M, Wang Y, Wu P, Li Z, Kong L, Han C. Zhang H, et al. Among authors: yan d. ACS Appl Mater Interfaces. 2023 Jan 19. doi: 10.1021/acsami.2c20312. Online ahead of print. ACS Appl Mater Interfaces. 2023. PMID: 36657998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,035 results

Search Page

Filters